北京美科美生物公司代理seegene

Respiratory Infections
Gastrointestinal
Tract Infections
Sexually
Transmitted
Infections
Human
Papillomavirus
Infections
Tuberculosis
Drug Resistance
Sepsis
Meningitis


Seegene通过各种商业机会和通过其优越的技术与众多全球公司的合作关系，重塑新的价值观。分子诊断市场的扩张和增长促进了Seegene多年来的持续增长。
分子诊断（MDx）是*新的体外诊断技术，通过分析DNA和RNA等含有遗传信息的核酸来检测疾病的病因。这种诊断方法具有高准确度和快速的结果传递能力，适用于早期诊断，并具有强大的个性化护理潜力。
分子诊断以其高灵敏度和准确性被用于检测传染性/遗传性疾病，近年来，它已被广泛用于检测MERS、H1N1和禽流感感染。


Seegene is recreating new values through various business opportunities and partnerships with numerous global companies through its superior technologies. Expansion and growth of molecular diagnostics market generates and contributes Seegene’s consistent growth over the years.
Molecular diagnostics (MDx) is the latest in vitro diagnostics that detects causes of disease by analyzing nucleic acids such as DNA and RNA which contain genetic information. Powered by high accuracy and rapid result delivery, this diagnostics is suitable for early diagnosis and holds a strong potential for personalized care.
With high sensitivity and accuracy, molecular diagnostics is used to detect infectious/genetic diseases, and in recent years, it has been widely used to detect MERS, H1N1, and avian influenza infections.